Quantitative assessment of the in-vitro binding kinetics of antisickling aromatic aldehydes with hemoglobin A: A universal HPLC-UV/Vis method to quantitate Schiff-base adduct formation.
Quantitative assessment of the in-vitro binding kinetics of antisickling aromatic aldehydes with hemoglobin A: A universal HPLC-UV/Vis method to quantitate Schiff-base adduct formation.
复制标题
抗镰化芳香醛与血红蛋白 A 的体外结合动力学的定量评估:定量席夫碱加合物形成的通用 HPLC-UV/Vis 方法。
DOI:
10.1016/j.jpba.2022.115152
复制
发表时间:
2023
影响因子:
3.4
通讯作者:
Venitz,Jürgen
中科院分区:
文献类型:
--
作者:
Xu,Xiaomeng;Ghatge,MohiniS;Huang,Boshi;Alghamdi,Ahmed;Wang,Huiqun;Pierce,BDaniel;Abdulmalik,Osheiza;Zhang,Yan;Safo,MartinK;Venitz,Jürgen
Aromatic aldehydes act as allosteric effectors of hemoglobin (AEH), forming Schiff-base adducts with the protein to increase its oxygen (O2) affinity; a desirable property in sickle cell disease (SCD) treatment, as the high-O2affinity hemoglobin (Hb) does not polymerize and subsequently prevents erythrocytes sickling. This study reports the development, validation, and application of a weak cation-exchange HPLC assay – quantifying the appearance of Hb-AEH adduct – as a “universal” method, allowing for the prioritization of AEH candidates through an understanding of their Hb binding affinity and kinetics. Concentration- and time-dependent Hb binding profiles of ten AEHs were determined with HPLC, followed by the appropriate non-linear modeling to characterize their steady-state binding affinity (KDss), and binding kinetics second-order association (kon) and first-order dissociation (koff) rate constants. Vanillin-derived AEHs exhibited enhanced binding affinity to Hb, primarily due to their faster kon. Across AEH, konand koffvalues are strongly correlated (r = 0.993, n = 7), suggesting that modifications of the AEH scaffold enhanced their interactions with Hb as intended, but inadvertently increased their Hb-AEH adduct dissociation. To our knowledge, the present study is the first to provide valuable insight into Hb binding kinetics of antisickling aromatic aldehydes, and the assay will be a useful platform in screening/prioritizing drug candidates for SCD treatment.